Xi Yan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Smoking Cessation

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Cancer medicine

World journal of surgery

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shuang Dai, Yong Zhang, Xiang Tan, Feng Luo, Xi Yan
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study. Cancer medicine 13 (11) (2024)
Shuang Dai, Yong Zhang, Xiang Tan, Feng Luo, Xi Yan
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study. Cancer medicine 13 (11) (2024)
Shuang Dai, Yong Zhang, Xiang Tan, Feng Luo, Xi Yan
Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study. Cancer medicine 13 (11) (2024)
Jiangping Yang, Jiaqi Han, Ni Zeng, Xi Yan
Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancer. Therapeutic advances in medical oncology 15 (2023)
YuPing Tan, Biao Yang, YuHong Chen, Xi Yan
Outcomes of Metaplastic Breast Cancer Versus Triple-Negative Breast Cancer: A Propensity Score Matching Analysis. World journal of surgery (2023)